Age-related macular degeneration (AMD) is a disease where abnormal blood vessels grow in the macula - the centre part of the retina - causing damage to the central vision and making it difficult to cope. Recent projections estimate that globally the number of individuals suffering with AMD will reach 288 million in 2040. In India, the overall prevalence of AMD currently ranges from 1.4 per cent to 3.1 per cent.
The earliest symptom of AMD is difficulty in seeing at night. At a later stage, AMD patients see blind spots and their ability to read, watch television, drive and recognise faces gets affected. It later progresses to blindness. The impaired vision disturbs the routine of the patients, makes them dependent and also increases functional disability.
"People suffering from AMD, who have lost over 80 per cent of their central vision are more likely to have anxiety and depression. This is mainly as they have plans to retire smoothly and find it difficult to read and perform recreational activities at this stage in life, which causes frustration and discomfort. Their life involves multiple visits to hospital accompanied with expensive treatments, which adds to deterioration in the quality of life," Dr. Indu Singh, Consultant Retinal surgeon and Director, Dr Daljit Singh Eye Hospital, Amritsar, told IANS.